May 18, 2026
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreApril 21, 2026
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreApril 21, 2026
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreJanuary 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreApril 21, 2026
Based on market forecasts, the cell and gene therapy CDMO sector will expand from USD 6.41 billion in 2024 to USD 75.32 billion by 2034, experiencing a CAGR of 27.94%. In 2024, North America led the cell and gene therapy CDMO market with a 41% share, while Asia Pacific is set for the fastest growth. Oncology dominated by indication, but rare diseas...
April 21, 2026
According to market projections, the topical drugs CDMO sector is expected to grow from USD 46.32 billion in 2024 to USD 136.71 billion by 2034, reflecting a CAGR of 11.43%. In 2024, Asia Pacific led the topical drugs CDMO market, with Latin America poised for strong growth. Semi-solid formulations and contract manufacturing dominated, while liquid...
April 21, 2026
Forecasts suggest that the small molecule CDMO market will expand from USD 72.81 billion in 2024 to USD 145.12 billion by 2034, with a CAGR of 7.14% during this period. In 2024, North America led the small molecule CDMO market, with APIs holding the largest product share and innovators dominating by drug type. Oncology was the top application. Look...
April 21, 2026
Based on market forecasts, the oligonucleotide CDMO sector will expand from USD 2.55 billion in 2024 to USD 18.37 billion by 2034, experiencing a CAGR of 21.83%. In 2024, North America led the oligonucleotide CDMO market, with Asia Pacific poised for the fastest growth. Contract manufacturing dominated by service, while contract development is set ...
April 21, 2026
According to forecasts, the global active pharmaceutical ingredients CDMO market will grow from USD 127.45 billion in 2024 to USD 260.98 billion by 2034, with an expected CAGR of 7.43%. In 2024, Asia-Pacific led the global API market, while North America is set for strong CDMO growth. Traditional APIs and synthetic synthesis dominated, but antibody...
April 21, 2026
According to forecasts, the global fertility market will grow from USD 36.57 billion in 2024 to USD 87.05 billion by 2034, with an expected CAGR of 9.06%. In 2024, Europe led the global fertility market share by 34%, while Asia-Pacific is set for the fastest growth ahead. Assisted reproductive technology dominated by offerings, while fertility drug...
April 21, 2026
Market insights predict the global bipolar disorder treatment industry will increase from USD 9.24 billion in 2024 to USD 15.67 billion by 2034, achieving a CAGR of 5.43%. In 2024, North America led the bipolar disorder treatment market, while Asia-Pacific is set for the fastest growth. Antipsychotics dominated by drug class, but antidepressants ar...
April 21, 2026
Based on market forecasts, the healthcare predictive analytics sector will expand from USD 18.13 billion in 2024 to USD 156.36 billion by 2034, experiencing a CAGR of 24.04%. In 2024, North America led the healthcare predictive analytics market share by 49%, with providers holding the largest share. The financial segment dominated by application, w...
April 21, 2026
Market insights predict the global polio vaccine industry will increase from USD 861.25 million in 2024 to USD 1406.89 million by 2034, achieving a CAGR of 5.03%. In 2024, North America led the polio vaccine market, with Asia-Pacific set for rapid growth. IPV dominated by type, while OPV is expected to grow fastest. Public applications held the lar...
April 21, 2026
According to market projections, the global lipid nanoparticles market, valued at USD 1.04 billion in 2024, is anticipated to reach USD 3.84 billion by 2034, growing at a CAGR of 13.97% over the next decade. In 2024, North America led the global lipid nanoparticles market, while Asia-Pacific is set for the fastest growth. Solid lipid nanoparticles ...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
